Input-output curves demonstrate motor cortex hyperexcitability associated with cognitive impairment in Alzheimer's disease
Authors:
- Julia H. ChoJCJulia H. Cho
- Brice PasseraBPBrice Passera
- Giacomo BertazzoliGBGiacomo Bertazzoli
- Recep Ali OzdemirRORecep Ali Ozdemir
- Basma GomaaBGBasma Gomaa
- Emma FerryEFEmma Ferry
- Alvaro Pascual-LeoneAPAlvaro Pascual-Leone
- Reisa A. SperlingRSReisa A. Sperling
- Daniel Z. PressDPDaniel Z. Press
- Mouhsin M. ShafiMSMouhsin M. Shafi
- Peter J. FriedPFPeter J. Fried
- Stephanie BussSBStephanie Buss
Preprint
- 23 May 2026
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
Recent studies suggest that cortical hyperexcitability in Alzheimer's disease (AD) may accelerate disease progression. However, the field lacks validated non-invasive methods to assay excitability in humans in vivo. In this study we used transcranial magnetic stimulation with electromyography to investigate mechanisms of cortical excitability in 63 biomarker-positive early-AD (ranging from mild cognitive impairment to mild dementia) participants and 72 cognitively unimpaired age-matched adults (CU). Single-pulse stimulation was applied to motor cortex to record resting motor thresholds (rMT) and motor-evoked potentials. An Input-Output curve was generated by delivering 10 pulses each at eight different intensities of maximum stimulator output (%MSO). Linear models or equivalent non-parametric tests 1) compared excitability metrics between groups, 2) tested correlations with cognition (mini-mental state exam, MMSE; Alzheimer’s disease assessment scale-cognitive, ADAS-Cog), and 2) tested the impact of APOE4. Results show that early-AD participants have greater excitability than CU, with lower rMT (p<0.001) lower Input-Output curve Inflection Point (p=0.007), and higher Dynamic Range (p=0.035). An analysis of the Input-Output curve adjusting for rMT showed larger responses in AD specifically in the 135-150% rMT range (p=0.023). In AD, higher excitability was related to worse cognition (rMT: MMSE p=0.008, Inflection Point: MMSE p=0.030 and ADAS-Cog p=0.041). There was no relationship between APOE4 allele status and excitability. In conclusion, AD participants have increased cortical excitability which is related to cognition. This is evident both at lower and higher stimulation intensities. TMS may provide a useful measure of target engagement for therapies aimed at preserving cognition or slowing decline in early-AD.Keywords
This publication has 49 references indexed in Scilit:
- Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationJAMA Neurology, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloidAlzheimer's & Dementia, 2024
- Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative DementiasAnnals of Neurology, 2020
- Incidence and impact of subclinical epileptiform activity in Alzheimer's diseaseAnnals of Neurology, 2016
- Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderlyHuman Brain Mapping, 2012
- Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation studyAnnals of Neurology, 2002
- Input-output properties and gain changes in the human corticospinal pathwayExperimental Brain Research, 1997
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- “Mini-mental state”Journal of Psychiatric Research, 1975